Literature DB >> 3217023

Experimental hydrocephalus and hydrosyringomyelia. Computertomographic studies.

E Donauer1, W Wussow, K Rascher.   

Abstract

Two methods were used to induce a model of experimental hydrocephalus and hydrosyringomyelia in the cat: a) injection of kaolin into the cisterna magna and b) closure of the lateral apertures of the fourth ventricle with cotton swabs. The pathological changes in the brain ventricles and the central canal of the spinal cord were monitored and documented at regular intervals by computed tomography (CT). The CT method is particularly advantageous for studies of this kind because the animals can be examined frequently without risking disturbances in cerebro-spinal fluid dynamics or tissue damage that would result from introduction of contrast media into the ventricular system. Our results and others reported earlier suggest that the dilated central canal acts as a kind of spontaneous CSF deviation route from the ventricles to the subarachnoid space. In spite of the tendency of the animals to recover in a clinical sense, the internal CSF space continued to expand; in cats the disease is progressive, a fact that is readily evident in follow-up CTs. This characteristic indicates that the spontaneous "shunt system" from the fourth ventricle through the dilated central canal to the spinal CSF spaces does not function well enough. Possible explanations for hydrocephalus compensation and the development of hydrosyringomyelia in experimental animals are discussed.

Entities:  

Mesh:

Year:  1988        PMID: 3217023     DOI: 10.1007/bf01795699

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  24 in total

1.  METHODS FOR PERFUSING DIFFERENT PARTS OF THE CAT'S CEREBRAL VENTRICLES WITH DRUGS.

Authors:  E A CARMICHAEL; W FELDBERG; K FLEISCHHAUER
Journal:  J Physiol       Date:  1964-10       Impact factor: 5.182

2.  Studies on the role of the choroid plexus in tracer exchanges between blood and cerebrospinal fluid.

Authors:  E A BERING
Journal:  J Neurosurg       Date:  1955-07       Impact factor: 5.115

3.  Myelomalacia and multiple cavitations of spinal cord secondary to adhesive arachnoiditis; an experimental study.

Authors:  R L McLAURIN; O T BAILEY; P H SCHURR; F D INGRAHAM
Journal:  AMA Arch Pathol       Date:  1954-02

4.  Radioisotope ventriculography in cats with kaolin-induced hydrocephalus.

Authors:  H M Eisenberg; J E McLennan; K Welch; S Treves
Journal:  Radiology       Date:  1974-02       Impact factor: 11.105

5.  The time-course of intracranial hypertension as recorded in conscious rabbits after treatment with different amounts of intracisternally injected kaolin.

Authors:  L Edvinsson; K A West
Journal:  Acta Neurol Scand       Date:  1971       Impact factor: 3.209

6.  Experimental hydrocephalus. Changes in cerebrospinal fluid dynamics as a function of time.

Authors:  G M Hochwald; W E Lux; A Sahar; J Ransohoff
Journal:  Arch Neurol       Date:  1972-02

7.  Evaluation of the central canal of the spinal cord in experimentally induced hydrocephalus.

Authors:  A E James; W J Flor; G R Novak; E P Strecker; B Burns
Journal:  J Neurosurg       Date:  1978-06       Impact factor: 5.115

8.  Iodide transfer at four cerebrospinal fluid sites in the dog: evidence for spinal iodide carrier transport.

Authors:  L A Coben; K R Smith
Journal:  Exp Neurol       Date:  1969-01       Impact factor: 5.330

9.  Changes in regional blood-flow and water content of brain and spinal cord in acute and chronic experimental hydrocephalus.

Authors:  G M Hochwald; R D Boal; A E Marlin; A J Kumar
Journal:  Dev Med Child Neurol Suppl       Date:  1975

10.  Terminal ventriculostomy for syringomyelia.

Authors:  W J Gardner; H S Bell; P N Poolos; D F Dohn; M Steinberg
Journal:  J Neurosurg       Date:  1977-05       Impact factor: 5.115

View more
  1 in total

Review 1.  Syringomyelia: a brief review of ontogenetic, experimental and clinical aspects.

Authors:  E Donauer; K Rascher
Journal:  Neurosurg Rev       Date:  1993       Impact factor: 3.042

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.